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Supplemental Methods 
Animals and Viral Vectors 
Esr1Cre/+ mice (see reference(1)) were generated and maintained at the California Institute of 
Technology (Caltech).   vGAT-Cre and vGLUT2-Cre mice were obtained from Jackson 
Laboratory.  All animal experiments were performed in accordance with NIH guidelines and 
approved by the Caltech Institutional Animal Care and Use Committee (IACUC).  Viral vectors: 
(1) For the anterograde projection study, AAV1-CAG-FLEX-EGFP (titer ~8x1012 viral 
genomes(vg)/ml) were obtained from the University of Pennsylvania Gene Therapy Program.  
(2) For the retrograde input study, Cre-dependent AAV1-Syn-DIO-TVA66T-dTom-CVS-N2cG 
(titer ~4x1013 vg/ml), AAV1-Syn-DIO-TVA66T-dTom (titer ~4x1013 vg/ml), and pseudotyped, 
G-deleted rabies viruses (EnvA-CVS-N2c-histone-GFP, 5 x109 infectious units (IU)/ml) were 
obtained from our collaborators at the Allen Institute for Brain Science (AIBS).  (3) For the 
anterograde trans-neuronal tracing study, Cre-dependent HSV1-H129ΔTK-TT (see reference (2) 
) was kindly provided by Lynn Enquist (Princeton University) with titer ~7 x109 plaque-forming 
units (pfu)/ml.  (4) For the collateral projection study, Cre-dependent retrograde HSV-hEF1-α-
LS1L-mCherry-IRES-flpo HT (titer ~3 x109 IU/ml) was obtained from Massachusetts Institute 
of Technology (MIT) McGovern Institute for Brain Research. AAVDJ-EF1α-fDIO-EYFP was 
obtained from the University of North Carolina at Chapel Hill Gene Therapy Center Vector Core 
(titer ~4 x1012 vg/ml).  (5) For tracing inputs based on projection (TRIO, see reference(3)), FLP-
dependent AAVDJ-CAG-fDIO-TVA-mCherry (titer ~2 x 1013 vg/ml) and FLP-dependent 
AAV8-CAG-fDIO-RG (titer ~4 x1012 vg/ml) were obtained from the Stanford University 
Neuroscience Gene Vector and Virus Core. Pseudo-typed, G-deleted rabies EnvA-ΔG-B19-GFP 
(titer ~4x108 transforming units (TU)/ml) were purchased from the Salk Institute Viral Vector 
Core.  Pseudo-typed, G-deleted rabies EnvA-N2c-GFP (titer ~2 x 108 IU/ml) were kindly 
provided by HHMI Janelia Virus Service Facility.  Cre-dependent retrograde HSV-hEF1-α-
LS1L-BFP-IRES-flpo HT for TRIO and Cre-dependent retrograde HSV-hEF1-α-LS1L-
mCherry/GFP for duel retrograde labeling were obtained from MIT McGovern Institute for 
Brain Research. 
Stereotaxic Surgery, Virus Injections, and immunohistochemistry 
Esr1cre mice (8-12 weeks old, male and female) were anaesthetized with 3-5% isoflurane for 
induction and 1-3% for maintenance. Mice were mounted on a stereotaxic frame (David Kopf 
Instruments) with heating pad placed underneath.  For anterograde tracing, AAV1-FLEX-EGFP 
viruses were injected by iontophoresis (3 µA at 7 s ‘on’ and 7 s ‘off’ cycles for 5 min total) with 
a pulled glass capillary (World Precision Company) into VMHvlEsr1.  Region of interest (ROI) 
was positioned using Model 1900 Stereotaxic Alignment System (David Kopf Instruments).  For 
VMHvl, coordinates are anteroposterior (AP): −1.5 mm from Bregma; mediolateral (ML): +0.78 
mm from the midline, dorsoventral (DV): −5.775 mm.  Mice were euthanized four weeks later 
with Ketamine (100 mg/kg) and Xylazine (10 mg/kg) and brains were analyzed by TissueCyte 
1000 serial two-photon (STP) tomography system at AIBS. 
For monosynaptic retrograde labeling, AAV1-DIO-TVA66T-dTom-N2cG (or AAV1-
DIO-TVA66T-dTom for rabies glycoprotein-less control) viruses were injected by iontophoresis 
(3 µA at 7 s 'on' and 7 2 'off' cycles for 5 min total) into the VMHvl of Esr1-cre male mice, 
followed by ~500 nl of rabies EnvA-N2c-histone-GFP with a Nanoliter 2010 injector (World 
Precision Company) three weeks later into the same location. Mice were euthanized 9 days later 
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and brains were analyzed by TissueCyte 1000 serial two-Photon (STP) tomography system at 
AIBS.  
For the glutamatergic and GABAergic inputs study, ~200 nl of HSV-LS1L-mCherry 
virus was injected into the VMHvl of vGLUT2-cre or vGAT-cre male mice (same coordinates as 
above, except ML= −0.78 for these and for injections described below).  Mice were euthanized 
~3 weeks later via perfusion with 4% PFA and serial sections were generated using a cryostat. 
For poly-synaptic anterograde tracing, ~150-300 nl of HSV1-H129ΔTK-TT viruses were 
injected into the VMHvl of Esr1-cre male mice with a Nanoliter injector and mice were 
euthanized between 40 to 48 hours after injection depending on assessments of their health.  
Ketoprofen (5 mg/kg, SQ) was given each day until euthanization. To visualize tdTomato 
encoded by HSV1-H129ΔTK-TT tracers, sections were stained with rat anti-mCherry (Thermo 
Fisher Scientific, clone 16D7, Cat# M11238, RRID:AB_253661, 1:200) overnight at 4 C, 
followed by Alexa-488-donkey anti-rat (Invitrogen, 1:200) at room temperature for 3 hours. For 
the collateral projection study, ~200 nl of HSV-LS1L-flpo viruses were injected into projection 
targets of VMHvlEsr1 neurons of Esr1-cre male mice  (LSv coordinates, AP= +0.14, ML= ⎯0.55, 
DV= ⎯4; PAG coordinates, AP= ⎯3.88, ML= ⎯0.137, DV= ⎯2.375; MPOA coordinates, AP= 
+0.02, ML= -0.3, DV= -5.375).  At the same time, ~200 nl of FLP-dependent AAVDJ-fDIO-
EYFP was injected into the VMHvl.  Mice were perfused with 4% PFA 28-30 days after 
injection and serial sections were made using a cryostat.  
For the projection-based input study, ~100-150 nl of HSV-LS1L-flpo viruses were 
injected into the projection targets (MPOA or PAG) of VMHvlEsr1 neurons in Esr1-cre male 
mice. At the same time, a 1:1 mixture of AAVDJ-fDIO-TVA and AAV8-fDIO-RG viruses were 
injected into the VMHvl (~150 nl total).  Three weeks later, rabies EnvA- ΔG-GFP was injected 
into the same location.  Mice were euthanized 6 days later via perfusion with 4% PFA and serial 
sections were generated using a cryostat.  
For duel-retrograde labeling, 200 nl of HSV-LS1L-mCherry and 200 nl of HSV-LS1L-
EYFP was injected into the PAG and MPOA, respectively, in the same VMHvlEsr1 male  mouse. 
Mice were euthanized ~3 weeks later via perfusion with 4% PFA and serial sections were 
generated using a cryostat. 
In all experiments, we targeted the Esr1+ cluster of the VMHvl, which forms a 
continuous population with the neighboring Tuberal nucleus (TU). The average % of viral back-
labeled cells in these two regions combined was 77% from 8 injected mice selected from across 
experiments. The remaining labeling could be found in other nearby regions that express Esr1, 
particularly the ventral premammillary nucleus (PMv) and Arcuate Hypothalamic nucleus 
(ARC).  
Image Acquisition and Analysis 
For projection and input studies, through collaborations with AIBS, brain samples with GFP-
labeled axonal projections or rabies-labeled cells were imaged using the TissueCyte 1000 serial 
two Photon (STP) tomography system (0.35 µm x-y resolution and 100 µm z-sampling interval) 
(see references (4, 5)). For quantification of projection strength or input neuron number, ROIs 
were selected and screenshots taken at the same magnification. Projection mapping images are 
publicly available and can be found at (http://connectivity .brain-map.org). Experiments used in 
the projection study are Experiments #176886958, #264248605, 264319363 posted on AIBS 
website (© 2015 Allen Institute for Brain Science. Allen Brain Atlas API. Available from: brain-
map.org/api/index.html).  Both Allen Mouse Brain Atlas (2004) and Allen Mouse Brain 
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Connectivity Atlas (2011) were used in this study.  Thirty ROIs were chosen based on (1) 
projection or input strength, (2) relative position, located anteriorly or posteriorly, to VMHvl, (3) 
research interests in psychiatric disorders and innate behaviors. For anterograde trans-neuronal 
tracing, collateral projections, glutamatergic vs. GABAergic inputs (INSERT), and projection-
based TRIO, images were acquired by confocal microscopy for starter cell images (Oympus 
FluoView FV1000), or by slide scanner for the quantification of starter cell location and labeling 
outside of the VMHvl (Olympus VS-ASW-S6).  For quantification, matching images of ROIs 
were obtained using the "Crop to Clipboard"  function of the slide scanner software.  Twenty-
eight ROIs (glutamatergic or GABAergic inputs), twenty ROIs (collateral projection), twelve 
ROIs (H129 transsynaptic anterograde tracing), and twenty-nine ROIs (TRIO) were chosen 
based on the criteria listed above. Additionally, for H129 labeling, SUBv, TTd, SFO, and SCH 
were chosen as we observed strong polysynaptic labeling. 
For quantification of projections, images were analyzed using Fiji/ImageJ by manually 
setting a threshold (common to all images) to the point that tissue autofluorescence was not 
visible followed by identification of objects using particle analysis (“analyze particles” function), 
binarization of the image, and summation of the total positive area (i.e. the area that is covered 
by projections above threshold). For quantification of input/output cell number, images were 
processed as described for projection analysis, except watershed-based identification of objects 
was used prior to particle analysis which was used for object counting, with size and circularity 
limited to an appropriate range to identify individual cells.  Automatic particle counting was 
visually inspected for accuracy and manually adjusted. For all ImageJ analysis, normalized 
projection strength or inputs were taken from three adjacent sections 30 or 60  µm apart.  For cell 
size and fiber mass quantifications, confocal images (60x) obtained using an Olympus FluoView 
1000 confocal were analyzed using Imaris Image Analysis Software (Bitplane, Oxford 
Instruments). To obtain optical image quality, stacked 60x confocal images of VMVHvl neurons 
were saved as OIB files and 3-D reconstructed using Imaris processing software followed by 
automated identification and quantification of fluorescent objects based on manually identified 
criteria (cells: volume threshold 100 µm^3; fibers: volume threshold 10 to 100 µm^3). 
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Figure S1, related to Figure 1.  Inputs to and outputs from VMHvlEsr1 neurons 
(A, B) Images taken with serial two-photon tomography of 30 regions showing projections from (A) and 
inputs to (B) VMHvlEsr1 neurons. Image credit (A): Allen Institute. Images are selected from Experiments 
#176886958, #264248605, 264319363 (see Methods). (C, D) Images from control experiments in which 
mice were injected with AAV-TVA66T with (C) or without (D) the rabies glycoprotein (RG). In mice 
without a supply of RG, there was no GFP labeling in any input regions except local GFP expression 
(arrow in D).  (E)  Schematic of experiment in which Cre-dependant, retrogradely-transported HSV-
mCherry was injected into the VMH of either vGlut2-cre or vGAT-cre mice.  (F) Representative images 
of glutamatergic (top panels) and GABAergic (bottom panels) inputs to VMHvl.  (G) Proportion of total 
glutamatergic (blue bars) or GABAergic (green bars) input neurons in 28 areas analyzed (normalized 
to=100%, mean+SEM, n=2).  (H) Schematic summarizing glutamatergic or GABAergic inputs to 
VMHvl.   
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Figure S2, related to Figure 2. Indirect feedback loops revealed by anterograde trans-synaptic 
tracing 
(A, E) Representative images of neurons labeled using the anterograde trans-synaptic tracer H129ΔTK-
TT; (B, F) AAV-GFP labeled projections. (C, G) Rabies-GFP-labeled inputs. Note the minimal labeling 
of AAV-GFP projections (B, F) and input (C), but strong trans-synaptic labeling in (A, E). (D) 
Quantification showing the percent of H129ΔTK-TT labeled output neurons in each of 12 selected 
regions (n=2, same data as Fig. 2). (H)  Quantification of proportion of inputs from 12 selected regions 
(mean+SEM, n=3).  Data in (H) were extracted from Figure 1L and normalized to 100% using the same 
12 regions for comparison to data in panel (D). (I-L) Control experiment for possible primary infection of 
axon terminals in anterograde tracing experiments in which a retrograde HSV (not HSV129) expressing 
cre-dependent mCherry was injected into the VMHvl of Esr1-cre mice. Little to no labeling is observed in 
the TTd, SCH, SFO, and SUBv. (M) Ratio of H129ΔTK-TT labeling to average input (i.e. data from D 
divided by data from H), for each region examined.  Note the large ratio for SCH. (N) Schematic of 
indirect feedback loops from VMHvlEsr1 to SFO and indirect output to SCH.  
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Figure S3, related to Figure 3 and 4.  VMHvlEsr1 subpopulations collateralize to multiple, distinct 
targets 
(A ) Schematic illustrating experimental strategy for labeling collaterals of VMHvlEsr1 neurons that 
project to the lateral septum (LSv). Representative images of coronal sections showing AAV-GFP 
expression in collateral projections of VMHvlEsr1 neurons that project to the LSv shown on the right. (B) 
Percent of total projection strength in each of 20 selected targets for VMHvlEsr1 neurons that project to the 
LSv (green bars, n=2) and VMHvlEsr1 neurons that project to the PAG (blue bars, n=3, data from Fig. 3). 
Bars show mean+SEM.  There is a strong interaction effect by 2-way ANOVA (p < 0.0001). (C) Scatter 
plot of the location along the A-P axis relative to the VMHvl (x-axis) vs the difference in percent of total 
collaterals observed in each region between LSv- and PAG-projecting populations (percent of total for 
LSv minus percent of total for PAG; y axis). There is a significant correlation between AP position and 
bias towards LSv (anterior regions) vs PAG (posterior regions) (R2 = 0.53, p<0.001). (D) Percent of total 
projection strength in each of 20 selected targets for VMHvlEsr1 neurons that project to the LSv (green 
bars, n=2, data same as in panel B) and VMHvlEsr1 neurons that project to the MPOA (orange bars, n=2, 
data from Fig. 3). Bars show mean+SEM.  There is no interaction effect by 2-way ANOVA (p = 0.4). (E) 
Scatter plot of the location along the A-P axis relative to the VMHvl (x-axis) vs the difference in percent 
of total collaterals observed in each region between LSv- and MPOA-projecting populations (percent of 
total for MPOA – percent of total for PAG; y axis). There is no significant correlation between AP 
position and bias towards collaterals of LSv vs MPOA (R2 = 0.013, p>0.5). (F) Images of viral labeling 
(top) and heatmap (bottom) showing the distribution of VMHvl neurons that project to the LSv and 
VMHvl neurons that project to the PAG along the A-P axis.  LSv-projecting neuronal somata are 
distributed more posteriorly than PAG-projecting ones (n=2/e). Data for PAG and MPOA projecting 
populations in panels B-F are the same as in Fig. 3C and Fig. 4A. 
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Figure S4, related to Figure 5.  VMHvlEsr1 starter cell locations 
Images (top) and heatmap (bottom) showing the distribution of VMHvlEsr1 starter cells from TRIO 
experiments - i.e. back-labeled either from the MPOA or PAG. Starter cell locations show a similar 
difference in A-P position as that seen in collateralization mapping experiments (cf. Fig. 4A). (n=2 for 
each population).   
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Abbreviation	used	 Full	name	
mPFC	 Medial	prefrontal	cortex	
PL	 Prelimbic	area	
ILA	 Infralimbic	area	
TTd	 Taenia	tecta,	dorsal	part	
LS	 Lateral	septal	nucleus	
adBNST	 Bed	nuclei	of	the	stria	terminalis,	anterior-dorsal	division	
BNSTpr	 Bed	nuclei	of	the	stria	terminalis,	principal	nucleus	
MPOA	 Medial	preoptic	area		
SCH	 Suprachiasmatic	nucleus		
SFO	 Subfornical	organ	
AHN	 Anterior	Hypothalamic	nucleus	
PVN	 Paraventricular	hypothalamic	nucleus	
SI	 Substantia	innominata	
CEA	 Central	amygdalar	nucleus	
ARC	 Arcuate	hypothalamic	nucleus	
MEA	 Medial	amygdalar	nucleus	
DMH	 Dorsomedial	nucleus	of	the	hypothalamus	
ZI	 Zona	incerta	
PRC	 Precommissural	nucleus	
PMv	 Ventral	premammillary	nucleus	
PA	 Posterior	amygdalar	nucleus	
NPC	 Nucleus	of	the	posterior	commissure	
SPFp	 Subparafascicular	nucleus,	parvicellular	part	
PIL	 Posterior	intralaminar	thalamic	nucleus	
VTA	 Ventral	tegmental	area	
SUBv	 Subiculum,	ventral	part	
MRN	 Mid	brain	reticular	nucleus	
PAGdm	 Periaqueductal	gray,	dorsomedial	area	
PAGvl	 Periaqueductal	gray,	ventrolateral	area	
PB	 Parabrachial	nucleus	
PCG	 Pontine	central	gray	
 
Table S1. Structures analyzed in this study and their abbreviations. Reference table showing 
abbreviations used in the text and figures of this study (left) and their full names (right).  
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Telencephalon  Esr1 projection Canteras PHA-L 
Orbitofrontal cortex ORBm +/- - 
Medial prefrontal cortex mPFC +/- +/- 
Dorsal peduncular cortex DP +/- - 
Tenia tecta, dorsal  TTd +/- - 
Agranular insular cortex AI +/- +/- 
Perirhinal cortex PERI +/- - 
Ectorhinal cortex ECT +/- - 
Piriform cortex PIR + +/- 
Bed N. accessory olfactory N. BA +/- - 
N. diagonal band NDB ++ +/- 
Subfornical organ SFO +/- - 
Substantia Innominata SI +++ + 
Medial septal N. MS ++ - 
Lateral septal N. LS ++ ++ 
Subiculum SUB +/- - 
Basolateral amygdala, anterior part BLAa ++ ++ 
Basolateral amygdala, posterior part BLAp ++ ++ 
Basal medial amygdala,  anterior part BMAa ++ ++ 
Central amygdala CEA +++ ++ 
Medial amygdala  MEA +++ ++ 
Posterior amygdala PA + +/- 
Amygdalo-piriform-transitional area TR +/- - 
Bed N. of stria terminalis, anterodorsal adBST +++ +++ 
Bed N. of stria terminalis, principal  BSTpr +++ +++ 
Diencephalon    
Paraventricular N. of thalamus PVT ++ + 
Precomissural N. PRC ++ - 
Subparafascicular N. posterior part SPFp + ++ 
Parataenial N. PT ++ - 
Medial habenular N. MH +/- - 
Lateral habenular N. LH + - 
Mediodorsal thalamic N. MD ++ +/- 
Peripeduncular area PP +/- +/- 
Hypothalamus    
Median preoptic area MEPO ++ +/- 
Medial preoptic area MPOA +++ ++++ 
Lateral preoptic area LPO +++ + 
Supraoptic N. SON +/- +/- 
Suprachiasmatic N. SCH + + 
Retrochiasmatic N. RCH +++ ++ 
Anterior hypothalamic  N. AHN +++ ++++ 
Paraventricular Hypothalamic N. PVN ++ +++ 
Anteroventral periventricular N. AVPV +++ + 
Periventricular N. of the hypothalamus PV + + 
Arcuate N. ARC ++ + 
Lateral hypothalamic N. LHA +++ + 
Ventromedial hypothalamic N. VMH ++ ++++ 
Doromedial hypothalamic N. DMH ++ +++ 
Ventral premammillary N. PMv + + 
Dorsal tuberomammillary N. TMd +/- +/- 
Supramamillary N. SUM ++ +/- 
Zona incerta ZI ++ + 
Posterior hypothalamic N. PH +++ ++ 
Midbrain    
Periaqueductal gray, dorsomedial  PAGdm ++++ +++ 
Peraqueductal gray, ventrolateral PAGvl ++++ +++ 
Midbrain reticular N. MRN +++ + 
Cuneiform N. CUN + + 
Nucleus of the posterior commissure NPC + +/- 
Dorsal Raphe DR + +/- 
Ventral tegmental area VTA ++ - 
Hindbrain    
Locus Coeruleus LC +/- +/- 
Pontine central gray PCG + - 
Lateral parabrachial N. LPB ++ +/- 
Kolliker-Fuse subnucleus KF +/- - 
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Table S2, related to Figure 1.  Comparison between anterograde viral tracing of Esr1+ VMHvl 
neurons and previously published PHAL tracing from the VMHvl. Table comparing results in this 
paper to those of a previous study tracing VMHvl projections using PHAL (See reference(6)). 
Quantifications from this study were converted to discrete values for purposes of comparison (e.g. “++”). 
Regions with labeling in this study but not in Canteras et al. (1994) are highlighted in yellow.     
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Table S3, related to Figure 1. Projections of VMHvl Esr1+ neurons in males vs. females. Comparison 
between male and female mice of the proportion of total projection strength to each region analyzed. 
Values for individual mice (2/e male and female) shown followed by their average (see Methods). No 
significant differences were observed between male and female mice by pairwise t-tests for all regions 
analyzed. 
	 	
Regions 
tested Male #82  Male #209 
Male 
Avg.±SEM 
Female 
#95 
Female 
#297 
Female 
Avg.±SEM 
TTEST btw 
males & females 
PH 2.30% 2.65% 2.48%±0.18% 1.98% 1.51% 1.75%±0.24% 0.14 
RE 1.24% 1.11% 1.18%±0.07% 1.12% 0.90% 1.01%±0.11% 0.35 
DMH 3.92% 4.09% 4.01%±0.09% 3.79% 3.96% 3.88%±0.09% 0.39 
PVT 0.96% 0.66% 0.81%±0.15% 0.95% 1.07% 1.01%±0.06% 0.39 
PMd 0.48% 0.61% 0.55%±0.07% 0.09% 0.54% 0.32%±0.23% 0.49 
CEA 2.01% 1.45% 1.73%±0.28% 1.81% 0.62% 1.22%±0.60% 0.54 
RCH 2.20% 2.51% 2.36%±0.16% 2.15% 4.19% 3.17%±1.02% 0.57 
PVpo 0.67% 0.86% 0.77%±0.10% 0.60% 2.20% 1.40%±0.80% 0.57 
MS 1.24% 1.01% 1.13%±0.12% 1.12% 0.97% 1.05%±0.08% 0.63 
VMH 2.30% 1.17% 1.74%±0.57% 1.55% 2.93% 2.24%±0.69% 0.63 
LPO 4.11% 2.96% 3.54%±0.58% 4.91% 3.23% 4.07%±0.84% 0.66 
MPO 7.46% 9.42% 8.44%±0.98% 7.84% 10.98% 9.41%±1.57% 0.66 
MEA 2.87% 1.84% 2.36%±0.52% 2.58% 1.38% 1.98%±0.60% 0.68 
LHA 14.26% 10.43% 12.35%±1.92% 13.09% 9.18% 11.14%±1.96% 0.70 
LSr 2.58% 1.37% 1.98%±0.61% 3.27% 1.60% 2.44%±0.84% 0.70 
PAG 10.43% 12.30% 11.37%±0.94% 13.35% 5.80% 9.58%±3.78% 0.72 
SI 3.92% 2.54% 3.23%±0.69% 3.88% 1.46% 2.67%±1.21% 0.74 
MRN 2.49% 2.03% 2.26%±0.23% 6.03% 0.73% 3.38%±2.65% 0.75 
ZI 2.30% 1.56% 1.93%±0.37% 2.41% 0.82% 1.62%±0.80% 0.77 
PVH 1.91% 2.47% 2.19%±0.28% 1.46% 3.49% 2.48%±1.02% 0.83 
PVp 0.57% 0.91% 0.74±%0.17% 0.17% 1.75% 0.96%±0.79% 0.83 
SCH 0.38% 0.62% 0.50%±0.12% 0.26% 0.92% 0.59%±0.33% 0.83 
AVPV 0.48% 1.05% 0.77%±0.29% 0.43% 1.35% 0.89%±0.46% 0.84 
PMv 0.38% 1.35% 0.87%±0.49% 0.34% 1.73% 1.04%±0.70% 0.86 
BST 8.90% 11.49% 10.20%±1.30% 8.44% 11.21% 9.83%±1.39% 0.86 
MPN 2.49% 4.49% 3.49%±1.00% 1.98% 5.73% 3.86%±1.88% 0.88 
PVi 0.48% 0.55% 0.52%±0.04% 0.17% 0.79% 0.48%±0.31% 0.93 
ARH 1.24% 1.52% 1.38%±0.14% 0.78% 1.88% 1.33%±0.55% 0.94 
SCm 3.35% 2.33% 2.84%±0.51% 4.82% 1.09% 2.96%±1.87% 0.96 
TU 2.97% 1.00% 1.99%±0.99% 1.55% 2.54% 2.05%±0.50% 0.96 
AHN 7.27% 9.55% 8.41%±1.14% 5.68% 10.85% 8.27%±2.59% 0.97 
SBPV 1.15% 1.21% 1.18±%0.03% 0.69% 1.72% 1.21%±0.52% 0.97 
MEPO 0.67% 0.91% 0.79%±0.12% 0.69% 0.88% 0.79%±0.10% 0.98 
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Telencephalon  Toth CTB Rabies tracing 
Orbitofrontal cortex ORBm +/- +/- 
Medial prefrontal cortex mPFC ++ ++ 
Dorsal peduncular cortex DP + + 
Tenia tecta, dorsal  TTd + ++ 
Agranular insular cortex AI +/- +/- 
Perirhinal cortex PERI +/- +/- 
Ectorhinal cortex ECT +/- +/- 
Piriform cortex PIR +/- +/- 
Bed N. accessory olfactory N. BA ++ ++ 
N. diagonal band NDB - +/- 
Subfornical organ SFO +/- +/- 
Substantia Innominata SI +/- +/- 
Medial septal N. MS - - 
Lateral septal N. LS ++ +++ 
Subiculum SUB ++++ ++++ 
Basolateral amygdala, anterior part BLAa - +/- 
Basolateral amygdala, posterior part BLAp + + 
Basal medial amygdala,  anterior part BMAa +/- +/- 
Central amygdala CEA - +/- 
Medial amygdala  MEA ++++ +++ 
Posterior amygdala PA ++++ +++ 
Amygdalo-piriform-transitional area TR + + 
Bed N. of stria terminalis, anterodorsal adBST ++++ ++++ 
Bed N. of stria terminalis, principal  BSTpr ++++ ++++ 
Diencephalon    
Paraventricular N. of thalamus PVT + + 
Precomissural N. PRC +/- + 
Subparafascicular N. posterior part SPFp +/- + 
Parataenial N. PT - - 
Medial habenular N. MH +/- +/- 
Lateral habenular N. LH - - 
Mediodorsal thalamic N. MD - - 
Peripeduncular area PP +/- +/- 
Hypothalamus    
Median preoptic area MEPO + + 
Medial preoptic area MPOA ++++ ++++ 
Lateral preoptic area LPO +++ +++ 
Supraoptic N. SON + + 
Striohypothalamic N. StHY +++ +++ 
Suprachiasmatic N. SCH +/- +/- 
Retrochiasmatic N. RCH +/- +/- 
Anterior hypothalamic  N. AHN ++ ++++ 
Paraventricular Hypothalamic N. PVN ++ +++ 
Anteroventral periventricular N. AVPV ++ +++ 
Periventricular N. of the hypothalamus PV ++ ++ 
Arcuate N. ARC ++ +++ 
Lateral hypothalamic N. LHA +/- + 
Ventromedial hypothalamic N. VMH +++ +++ 
Doromedial hypothalamic N. DMH ++ +++ 
Ventral premammillary N. PMv ++ ++++ 
Dorsal tuberomammillary N. TMd ++ ++ 
Supramamillary N. SUM +/- +/- 
Zona incerta ZI - +/- 
Posterior hypothalamic N. PH ++ ++ 
Midbrain    
Periaqueductal gray, dorsomedial  PAGdm +/- +/- 
Peraqueductal gray, ventrolateral PAGvl +/- +/- 
Midbrain reticular N. MRN - +/- 
Cuneiform N. CUN +/- +/- 
Nucleus of the posterior commissure NPC - +/- 
Dorsal Raphe DR +/- + 
Ventral tegmental area VTA +/- +/- 
Hindbrain    
Locus Coeruleus LC +/- +/- 
Pontine central gray PCG - +/- 
Lateral parabrachial N. LPB ++ ++ 
Kolliker-Fuse subnucleus KF + + 
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Table S4, related to Figure 1. Inputs to VMHvl Esr1+ neurons vs. previous CTB tracing of VMH 
inputs. Table comparing results in this paper using rabies virus to trace inputs to genetically-defined 
Esr1+ neurons to those of a previous study tracing VMH inputs using CTB (see reference(7)). 
Quantifications from this study were converted to discrete values for purposes of comparison (e.g. “++”). 
Regions with labeling in this study but not in Toth et al. (2010) are highlighted in yellow.     
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Rank	 Region	
Inputs	
Rank	 Region	
Projections	
Average	%	 SEM	(%)	 Average	%	 SEM	(%)	
1	 MPOA	 8.89%	 0.41%	 1	 AHN	 9.51%	 0.48%	
2	 AHN	 7.91%	 1.37%	 2	 MPOA	 8.90%	 0.97%	
3	 PMv	 7.82%	 1.04%	 3	 DMH	 7.94%	 0.42%	
4	 AVPV	 6.77%	 0.61%	 4	 PVN	 7.63%	 1.06%	
5	 BNSTpr	 6.57%	 0.75%	 5	 PMv	 6.64%	 0.35%	
6	 PA	 6.46%	 0.7%	 6	 PAGvl	 5.92%	 1.09%	
7	 SUBv	 6.34%	 0.64%	 7	 SI	 5.60%	 0.52%	
8	 adBNST	 6.31%	 0.67%	 8	 AVPV	 5.41%	 0.36%	
9	 MEA	 5.44%	 1.08%	 9	 adBNST	 5.34%	 1.38%	
10	 PVN	 4.91%	 0.32%	 10	 ARC	 4.74%	 0.84%	
11	 DMH	 4.91%	 0.58%	 11	 PAGdm	 3.55%	 0.20%	
12	 LS	 4.44%	 0.15%	 12	 PRC	 3.06%	 0.42%	
13	 ARC	 4.18%	 0.88%	 13	 BNSTpr	 2.76%	 0.67%	
14	 TTd	 3.20%	 0.51%	 14	 CEA	 2.67%	 0.12%	
15	 PB	 2.43%	 0.35%	 15	 PVT	 2.48%	 0.36%	
16	 SPFp	 1.89%	 0.53%	 16	 SPFp	 2.46%	 0.24%	
17	 PAGvl	 1.81%	 0.10%	 17	 NPC	 2.13%	 0.12%	
18	 CEA	 1.62%	 0.24%	 18	 PB	 1.97%	 0.24%	
19	 PCG	 1.37%	 0.22%	 19	 MRN	 1.93%	 0.12%	
20	 mPFC	 1.30%	 0.30%	 20	 PCG	 1.86%	 0.10%	
21	 PRC	 1.21%	 0.09%	 21	 LS	 1.75%	 0.18%	
22	 SI	 0.85%	 0.14%	 22	 PA	 1.74%	 0.19%	
23	 SFO	 0.68%	 0.07%	 23	 MEA	 1.35%	 0.08%	
24	 NPC	 0.60%	 0.19%	 24	 VTA	 0.88%	 0.30%	
25	 VTA	 0.58%	 0.21%	 25	 ZI	 0.81%	 0.21%	
26	 PAGdm	 0.43%	 0.08%	 26	 SCH	 0.53%	 0.06%	
27	 MRN	 0.33%	 0.05%	 27	 mPFC	 0.27%	 0.12%	
28	 ZI	 0.28%	 0.15%	 28	 SUBv	 0.07%	 0.04%	
29	 PVT	 0.28%	 0.06%	 29	 TTd	 0.04%	 0.02%	
30	 SCH	 0.18%	 0.04%	 30	 SFO	 0.03%	 0.01%	
	
Table S5., related to Figure 1, inputs and outputs to VMHvlEsr1 neurons. Table showing percent of 
total input neurons and percent of total projection strength for the top 30 regions/each, rank-ordered by 
relative strength. Data were collected from micrographs of 3 adjacent sections per region per brain from 
three brains/each (see Methods). See Supplemental Figure 1 for micrographs.  
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Rank	 Projection	targets	
Percent	
of	total	projections	
Percent	
Of	total	Inputs	
Ratio:	
projection/input	
1	 PVT	 2.48%	 0.28%	 8.9	
2	 PAGdm	 3.55%	 0.43%	 8.3	
3	 SI	 5.60%	 0.85%	 6.6	
4	 MRN	 1.93%	 0.33%	 5.8	
5	 NPC	 2.13%	 0.60%	 3.6	
6	 PAGvl	 5.92%	 1.81%	 3.3	
Rank	 Input	regions	 Percent	of	total	Inputs	
Percent	
of	total	projections	
Ratio:	
inputs/projections	
1	 SUBv	 6.34%	 0.07%	 90.6	
2	 TTd	 3.20%	 0.04%	 80.0	
3	 SFO	 0.68%	 0.03%	 22.7	
4	 mPFC	 1.30%	 0.27%	 4.8	
5	 MEA	 5.44%	 1.35%	 4.0	
6	 PA	 6.46%	 1.74%	 3.7	
	
Table S6., related to Figure 1, top six input-biased and output-biased regions. Table showing the 
regions that are most biased towards being projection targets of (left) versus sending inputs to (right) 
VMHvl Esr1+ neurons. See Table S5 for quantification of inputs and projections for each region.  
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Table S7, related to Figure 1 and Table S5 and S6.   Positional bias of input-preferred vs. output 
preferred regions. Table showing the top 10 input-biased (left) and output-biased (center) regions, and 
regions with no bias (right), their ratios of input to output strength, and their location relative to bregma. 
Pairwise t-tests show that there is a significant difference in the A-P location of input biased vs projection 
biased regions, with input-biased regions located anterior to projection-biased regions. No significant 
differences are observed when comparing biased regions to regions with no bias.  
 
  
Rank Input 
pref. 
Ratio 
input/ 
output 
Dist. to 
Bregma 
(mm) 
Top 10 
output 
pref. 
 
Ratio 
output/ 
input  
Dist. to 
Bregma 
(mm) 
No pref. 
 
Dist. to 
Bregma 
(mm) 
TTEST 
(col 4v7) 
TTEST 
(col 4v9) 
TTEST 
(col7v9) 
1 SUBv 90.6 -3.78 PVT 8.9 -0.88 MPOA 0.02 p=0.0297 p=0.0997 p=0.7191 
2 TTd 80 1.545 PAGdm 8.3 -4.78 ARC -1.455    
3 SFO 22.7 -0.655 SI 6.6 -1.055 adBNST 0.145 
4 mPFC 4.8 1.945 MRN 5.8 -3.88 PB -5.38 
5 MEA 4 -1.555 NPC 3.6 -2.555 AHN -0.655 
6 PA 3.7 -2.255 PAGvl 3.3 -4.78 SPFp -2.78 
7 LS 2.5 1.045 SCH 2.9 -0.655 PCG -5.38 
8 BNSTpr 2.4 -0.18 ZI 2.9 -2.155 VTA -3.455 
9 AVPV 1.3 0.245 PRC 2.5 -2.255 PVN -0.655 
10 PMv 1.2 -2.255 CEA 1.6 -1.155 DMH -1.555 
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